Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

An HIV support group for children at Epworth Clinic on Harare’s outskirts. MSF has set up community support groups for HIV patients from the Clinic. At Epworth, children and young people come together to give each other support. Through games and education they learn about HIV and how they can live a healthy life. Photograph by Rachel Corner
Press release
Press release |
07 June 2016
HIV/AIDS
Africa

MSF: Governments at UN must address severe lack of HIV treatment access in West and Central Africa during High-Level Meeting

5 min
A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office to safeguard India's patent laws for companies to produce affordable generic medicines. Photograph by Guddu
Press release
Press release |
02 June 2016
Intellectual property and trade
India

Ahead of Prime Minister Modi's Visit, Doctors Without Borders Urges India to Put People’s Health Before Pharmaceutical Profits

4 min
Staff at the Epworth clinic pharmacy preparing medication to be collected by patient. Photograph by Ikram N'gadi Photograph by Ikram N'gadi
Press release
Press release |
27 May 2016
Antimicrobial resistance
G7Japan

No guts from G7 leaders to tackle one of the biggest threats to global health

A group of mothers with their children line up to receive their drugs at a hospital pharmacy in Bossangoa, in the northwest region of the Central African Republic, June 2013. Photograph by Ton Koene
Press release
Press release |
26 May 2016
Intellectual property and trade

MSF calls on G7 leaders to urgently address the critical gaps in global response to public health emergencies and unite to lower the price of live-saving medicines

4 min
Press release |
24 May 2016

Médecins Sans Frontières Access Campaign Executive Director steps down

National TB Centre, Abovian, Armenia February 2010. The injections, pills and powders DR TB patients must take are toxic antibiotics, the most recent of which was developed 40 years ago. Most patients suffer side effects that can sometimes cause more discomfort than the disease. Photograph by Bruno De Cock
Press release
Press release |
18 May 2016
Antimicrobial resistance
United Kingdom

MSF response to O’Neill report on antimicrobial resistance

Metro advertisements for Doctors Without Borders, 2015. Photograph by Drew Angerer
Press release
Press release |
16 May 2016
Intellectual property and trade

Countries Must Reject Further Changes to the TPP That Would Worsen Access to Affordable Medicines

3 min
Metro advertisements for Doctors Without Borders, 2015. Photograph by Drew Angerer
Press release
Press release |
12 May 2016
Intellectual property and trade
MexicoPeru

Key Latin American countries must reject harmful TPP agreement that will keep medicine prices unaffordable

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury